Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2006
04/13/2006WO2006037328A1 Polypeptides having phytase activity and polynucleotides encoding same
04/13/2006WO2006037327A2 Polypeptides having phytase activity and polynucleotides encoding same
04/13/2006WO2006037215A1 Expression system, components thereof and methods of use
04/13/2006WO2006016167A3 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc.
04/13/2006WO2006015326A3 Methods of isolating nucleic acids using multifunctional group-coated solid phase carriers
04/13/2006WO2006011795A3 Method for preventing dehiscence and altering plant lignification
04/13/2006WO2005123942A3 Analysis of methylated nucleic acid
04/13/2006WO2005123937A3 Methods for expressing rnp particles in eukaryotic cells
04/13/2006WO2005121372A3 Double strand compositions comprising differentially modified strands for use in gene modulation
04/13/2006WO2005121351A3 Methods for transforming and expression screening of filamentous fungal cells with a dna library
04/13/2006WO2005117897A3 Hepoxilins and modulators of ichthyin for treatment skin disorders
04/13/2006WO2005116255A3 Aptamer-toxin molecules and method for using same
04/13/2006WO2005116199A3 Tobacco nicotine demethylase genomic clone and uses thereof
04/13/2006WO2005108620A3 Processing polynucleotide-containing samples
04/13/2006WO2005100576A3 Replication competent viruses capable of silencing virus inhibitory factor expression
04/13/2006WO2005095632A3 Methods for identifying proteins with starch phosphorylating enzymatic activity
04/13/2006WO2005095622A3 c-met siRNA ADENOVIRUS VECTORS INHIBIT CANCER CELL GROWTH, INVASION AND TUMORIGENICITY
04/13/2006WO2005090572A3 Compositions and methods for treating pancreatic cancer
04/13/2006WO2005062820A3 Multi plasmid system for the production of influenza virus
04/13/2006WO2005060328A3 ENCODING NUCLEOTIDES OF GENES FROM THE CHROMOSOME OF THE BACTERIUM Mycoplasma hyopneumoniae, EXPRESSION AND ACTIVITY OF THE POLYNUCLEOTIDES AND THEIR APPLICATIONS
04/13/2006WO2005056806A3 Viral vectors controlled by a gene switch
04/13/2006WO2005041758A3 Novel cell-based assays employing voltage and calcium dyes
04/13/2006WO2005032460A3 Human epo mimetic hinge core mimetibodies, compositions, methods and uses
04/13/2006WO2005012876A3 Methods of screening compositions for g protein-coupled receptor desensitization inhibitory activity
04/13/2006WO2005002507A3 Modulation of survivin expression
04/13/2006WO2004104169A3 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
04/13/2006WO2004101757A3 Production of polyunsaturated fatty acids in oleaginous yeasts
04/13/2006WO2004009769A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
04/13/2006WO1995019374A9 Bacterial receptor structures
04/13/2006US20060080750 Nucleic acid constructs and methods for producing altered seed oil compositions
04/13/2006US20060080749 Transgenic plants or cells comprising an inhibitory nucleic acid specific for one or more nematode esophageal polypeptides; root-knot nematode
04/13/2006US20060080748 Cross-incompatibility traits from teosinte and their use in corn
04/13/2006US20060080747 Constitutive expression cassettes for regulation of plant expression
04/13/2006US20060080745 Gene reactivation by somatic hypermutation
04/13/2006US20060080744 Novel chemokine-like polypeptides
04/13/2006US20060079670 98 human secreted proteins
04/13/2006US20060079580 Production of mutant strain of aspergillus fumigatus, method of assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection
04/13/2006US20060079512 10-farnesyl-4,6,8-tri(bisbenzyloxyphosphoryloxy)-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one; antitumor, anticarcinogenic agent; solid (pancreatic, prostate, colorectal, lung, ovarian cancer) or hematopoietic (leukemia or lymphoma) neoplasm; bactericide, inhibitor of 5-lipoxygenase, cyclooxygenase-2
04/13/2006US20060079509 Antineoplastic agents; inhibitors of cancer cell growth, mammalian lipoxygenase, acute and chronic inflammation
04/13/2006US20060079488 Methods of treating and preventing bone loss
04/13/2006US20060079477 High affinity nucleic acid ligands of complement system proteins
04/13/2006US20060079471 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids
04/13/2006US20060079470 Combined dna vaccine and biological modifiers for cancer therapy
04/13/2006US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same
04/13/2006US20060078996 Surface transfection and expression procedure
04/13/2006US20060078992 protein biosynthesis inhibitor resistance genes capable of imparting cycloheximide resistance to animal cells sensitive to the inhibitor; genes have sequences mutated by substitution in a gene coding a ribosome-constituting protein derived from an animal; expression vectors; genetic engineering
04/13/2006US20060078981 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms
04/13/2006US20060078980 Production of polyketides and other natural products
04/13/2006US20060078977 Novel purified polypeptides from Enterococcus faecalis
04/13/2006US20060078972 Production of 5'-ribonucleotides
04/13/2006US20060078969 Regulated transcription of targeted genes and other biological events
04/13/2006US20060078968 introducing a DNA comprising a nucleotide sequence containing recombination sequence into a cell, and performing the sequence specific recombination by a bacteriophage lambda integrase Int
04/13/2006US20060078967 Antibodies for IL-17 receptor like polypeptides and uses thereof
04/13/2006US20060078966 IL-17 receptor like polypeptides and uses thereof
04/13/2006US20060078963 Methods for producing modified glycoproteins
04/13/2006US20060078957 A host cell containing an expression vector for an aggrecanase to use as a drug screening agent for joint diseases
04/13/2006US20060078952 Method for identifying antimicrobial molecules which interfere with apolipoprotein N-acyltransferase activity
04/13/2006US20060078950 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
04/13/2006US20060078946 Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific B lymphocyte and method for manufacturing monoclonal antibody
04/13/2006US20060078940 21132, a human G-protein coupled receptor family member and uses therefor
04/13/2006US20060078937 Sequencing single nucleic acid template molecules eliminates the need for amplification prior to initiation of sequencing; Long read lengths of sequence can be deduced in one run eliminating need for extensive computational methods to assemble a gap-free full length sequence of long template molecules
04/13/2006US20060078936 Solid support assay systems and methods utilizing non-standard bases
04/13/2006US20060078934 Method for acceleration and intensification of target-receptor binding and devices therefor
04/13/2006US20060078933 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation
04/13/2006US20060078932 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
04/13/2006US20060078928 Isolated from thermophilic archaebacterium Archaeoglobus fulgidus; stable under polymerase chain reaction conditions and exhibits exonuclease activity
04/13/2006US20060078923 Method for isolating nucleic acids
04/13/2006US20060078922 Novel purified polypeptides from haemophilus influenzae
04/13/2006US20060078921 Biomarkers and expression profiles for toxicology
04/13/2006US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
04/13/2006US20060078909 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
04/13/2006US20060078907 Nanomachine compositions and methods of use
04/13/2006US20060078903 Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions
04/13/2006US20060078902 Method and compositions for RNA interference
04/13/2006US20060078901 Listeria monocytogenes genome, polypeptides and uses
04/13/2006US20060078884 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
04/13/2006US20060078880 Zinc finger libraries
04/13/2006US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
04/13/2006US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription
04/13/2006US20060078565 Nucleic acids and proteins from Group B Streptococcus
04/13/2006US20060078554 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage
04/13/2006US20060078552 Hybrid and single chain meganucleases and use thereof
04/13/2006US20060078551 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python
04/13/2006US20060078545 Neural progenitor cell populations
04/13/2006US20060078543 Neural progenitor cells derived from embryonic stem cells
04/13/2006US20060078542 Gel-based delivery of recombinant adeno-associated virus vectors
04/13/2006US20060078539 Remedies for tumor in hematopoietic organs
04/13/2006DE102004048381A1 New nucleic acid encoding a mutant VPS54 polypeptide, useful for in vitro screening for the wobbler genotype, associated with, e.g. motor system or neurodegenerative diseases
04/13/2006DE102004047777A1 Alpha-Amylase-Varianten mit erhöhter Lösungsmittelstabilität, Verfahren zu deren Herstellung sowie Wasch- und Reinigungsmittel mit diesen Alpha-Amylase-Varianten Alpha-amylase variants with increased solvent stability, process for their preparation and washing and cleaning products containing these alpha-amylase variants
04/13/2006CA2847930A1 Assay for detecting and quantifying hiv-1
04/13/2006CA2615139A1 Piscirickettsia salmonis antigens and use thereof
04/13/2006CA2610106A1 Polypeptides having phytase activity and polynucleotides encoding same
04/13/2006CA2601422A1 Polypeptides having phytase activity and polynucleotides encoding same
04/13/2006CA2589602A1 Adenoviral vectors able to transduce apcs, potential use in immune response generation
04/13/2006CA2588243A1 Corn event das-59122-7 and methods for detection thereof
04/13/2006CA2583514A1 Method for producing basic substance
04/13/2006CA2583431A1 Variant amyloid protein
04/13/2006CA2583422A1 Vascular plants expressing na+ pumping atpases
04/13/2006CA2583065A1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
04/13/2006CA2582963A1 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents